Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37201 - 37225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	FJX1	24147	downregulated	entinostat results in decreased expression of FJX1 mRNA	11p13	A21037
Entinostat	Investigational	FKBP11	51303	upregulated	entinostat results in increased expression of FKBP11 mRNA	12q13.12	A21037
Entinostat	Investigational	FKBP14	55033	upregulated	entinostat results in increased expression of FKBP14 mRNA	7p14.3	A21035
Entinostat	Investigational	FKBP5	2289	upregulated	entinostat results in increased expression of FKBP5 mRNA	6p21.31	A21037 A21035
Entinostat	Investigational	FKBP7	51661	upregulated	entinostat results in increased expression of FKBP7 mRNA	2q31.2	A21035
Entinostat	Investigational	FKBP9	11328	upregulated	entinostat results in increased expression of FKBP9 mRNA	7p14.3	A21035
Entinostat	Investigational	FLNB	2317	upregulated	entinostat results in increased expression of FLNB mRNA	3p14.3	A21037 A21035
Entinostat	Investigational	FLRT1	23769	upregulated	entinostat results in increased expression of FLRT1 mRNA	11q13.1	A21035
Entinostat	Investigational	FLRT2	23768	downregulated	entinostat results in decreased expression of FLRT2 mRNA	14q31.3	A21037
Entinostat	Investigational	FLT1	2321	upregulated	entinostat results in increased expression of FLT1 mRNA	13q12.3	A21037
Entinostat	Investigational	FMC1	154791	downregulated	entinostat results in decreased expression of FMC1 mRNA	7q34	A21035
Entinostat	Investigational	FMN1	342184	upregulated	entinostat results in increased expression of FMN1 mRNA	15q13.3	A21035
Entinostat	Investigational	FMO4	2329	upregulated	entinostat results in increased expression of FMO4 mRNA	1q24.3	A21035
Entinostat	Investigational	FMO5	2330	downregulated	entinostat results in decreased expression of FMO5 mRNA	1q21.1	A21035
Entinostat	Investigational	FMOD	2331	upregulated	entinostat results in increased expression of FMOD mRNA	1q32.1	A21035
Entinostat	Investigational	FN1	2335	upregulated	entinostat results in increased expression of FN1 mRNA	2q35	A21035
Entinostat	Investigational	FNDC1	84624	upregulated	entinostat results in increased expression of FNDC1 mRNA	6q25.3	A21037 A21035
Entinostat	Investigational	FNDC3A	22862	downregulated	entinostat results in decreased expression of FNDC3A mRNA	13q14.2	A21035
Entinostat	Investigational	FNDC3B	64778	upregulated	entinostat results in increased expression of FNDC3B mRNA	3q26.31	A21035
Entinostat	Investigational	FNTB	2342	upregulated	entinostat results in increased expression of FNTB mRNA	14q23.3	A21035
Entinostat	Investigational	FOS	2353	downregulated	entinostat results in decreased expression of FOS mRNA	14q24.3	A21037
Entinostat	Investigational	FOSL1	8061	upregulated	entinostat results in increased expression of FOSL1 mRNA	11q13.1	A21037
Entinostat	Investigational	FOXD1	2297	upregulated	entinostat results in increased expression of FOXD1 mRNA	5q13.2	A21035
Entinostat	Investigational	FOXD3	27022	upregulated	entinostat results in increased expression of FOXD3 mRNA	1p31.3	A21037 A21035
Entinostat	Investigational	FOXG1	2290	downregulated	entinostat results in decreased expression of FOXG1 mRNA	14q12	A21037

Displaying entries 37201 - 37225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability